Influenza

Data show the weighted influenza vaccination rate among pregnant women was 54.5%, with one third not having a usual source of care.

Though seasonal flu activity has remained low, the number of influenza virus detections reported by clinical and public health laboratories had increased in recent weeks.

New data from the CDC highlights the need to mitigate the potential severity of the influenza season, particularly with COVID-19's substantial impact on care systems.

COVID-19 mitigation measures resulted in a historically low influenza season.

A CDC analysis shows more doses were administered adults and adolescents than in previous years, while COVID-19 factors may have influenced the dip in shots among children.

The vaccine design reduces the amount of antigen required to produce an immune response.

Investigators found once some of the nonpharmacological interventions were relaxed some viruses returned to historical average case rates.

ContagionLive releases their latest e-book on this year's flu season, which includes expert-led opinions and interviews.

An estimated 23% of healthcare personnel contract influenza annually.

This study looks at the risk of adverse events following immunization by comparing the safety profile of the mRNA COVID-19 vaccines to the safety profile of the influenza vaccines.

Patients and physicians alike approved of the overall design of the tool, which aided patients in identifying preventive services featured in the study.

Approximately 50% of children with laboratory-confirmed influenza in 2015 - 2016 were treated with antivirals, despite recommendations on their use.

Lactate dehydrogenase levels were significantly higher in patients with Influenza A.

The new indication makes the quadrivalent Seqirus flu shot available for every US-eligible patient age group.

Michael Greenberg, MD, MPH, and Rick Nettles, MD, join Lungcast to discuss COVID-19 vaccine development, the 2021-22 flu season, RSV outbreaks, and more respiratory viruses.

Data show the outcome of all-cause mortality, MI, or stent thrombosis occurred in 5.3% of patients vaccinated against the flu and 7.2% of patients who were given placebo.

Data show a 23.5% increase in influenza vaccination rates.

ClearUp Sinus Pain Relief treatment was previously approved for allergy-related sinus and nasal congestion and allergy-related sinus pain.

The approval is based on absolute efficacy data from 3 influenza seasons.

Compared with US census data, White individuals and women are overrepresented in clinical trials.

Women were more likely than men to get the influenza vaccine, but less likely to receive the high-dose version.

Partnerships between primary care physicians and pulmonologists may improve vaccination rates for patients with COPD.

An expert weighs in on the strengths, makeup, and timeframe of current and upcoming vaccine options.

A meta-analysis review suggests intradermal flu vaccines at lower doses could provide as much immunogenicity as standard intramuscular doses.